SARACELI SALAS: Open Payments
NPI 1356072052 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 35 payments from 6 companies in 2025. Trend: 2023 $34 · 2024 $454 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 11 | $304 |
| Madrigal Pharmaceuticals | 5 | $160 |
| ABBVIE INC. | 12 | $147 |
| Janssen Biotech, Inc. | 3 | $137 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: IQIRVO, REZDIFFRA, TREMFYA, LINZESS, XIFAXAN, CREON, RINVOQ, VOWST.
Industry payments across TX — which companies pay providers there.
